157 related articles for article (PubMed ID: 12384202)
1. Functional ovarian cysts in premenopausal and gynecologically healthy women.
Christensen JT; Boldsen JL; Westergaard JG
Contraception; 2002 Sep; 66(3):153-7. PubMed ID: 12384202
[TBL] [Abstract][Full Text] [Related]
2. Ovarian volume in gynecologically healthy women using no contraception, or using IUD or oral contraception.
Christensen JT; Boldsen J; Westergaard JG
Acta Obstet Gynecol Scand; 1997 Sep; 76(8):784-9. PubMed ID: 9348259
[TBL] [Abstract][Full Text] [Related]
3. Prevalence of extrauterine pelvic lesions on transvaginal ultrasound in asymptomatic 20-39-year-old women.
Jokubkiene L; Sladkevicius P; Valentin L
Ultrasound Obstet Gynecol; 2014 Aug; 44(2):228-37. PubMed ID: 24375888
[TBL] [Abstract][Full Text] [Related]
4. Oral contraceptive type and functional ovarian cysts.
Lanes SF; Birmann B; Walker AM; Singer S
Am J Obstet Gynecol; 1992 Mar; 166(3):956-61. PubMed ID: 1550172
[TBL] [Abstract][Full Text] [Related]
5. Effects of pretreatment with an oral contraceptive on the time required to achieve pituitary suppression with gonadotropin-releasing hormone analogues and on subsequent implantation and pregnancy rates.
Biljan MM; Mahutte NG; Dean N; Hemmings R; Bissonnette F; Tan SL
Fertil Steril; 1998 Dec; 70(6):1063-9. PubMed ID: 9848296
[TBL] [Abstract][Full Text] [Related]
6. Ovarian cysts: presence and persistence with use of a 13.5mg levonorgestrel-releasing intrauterine system.
Nahum GG; Kaunitz AM; Rosen K; Schmelter T; Lynen R
Contraception; 2015 May; 91(5):412-7. PubMed ID: 25661510
[TBL] [Abstract][Full Text] [Related]
7. Comparison of low-dose monophasic oral contraceptive pills and expectant management in treatment of functional ovarian cysts.
Sanersak S; Wattanakumtornkul S; Korsakul C
J Med Assoc Thai; 2006 Jun; 89(6):741-7. PubMed ID: 16850671
[TBL] [Abstract][Full Text] [Related]
8. Intracervical and fundal administration of levonorgestrel for contraception: endometrial thickness, patterns of bleeding, and persisting ovarian follicles.
Pakarinen PI; Suvisaari J; Luukkainen T; Lähteenmäki P
Fertil Steril; 1997 Jul; 68(1):59-64. PubMed ID: 9207585
[TBL] [Abstract][Full Text] [Related]
9. Ovarian function during low-dose oral contraceptive use.
Egarter C; Putz M; Strohmer H; Speiser P; Wenzl R; Huber J
Contraception; 1995 Jun; 51(6):329-33. PubMed ID: 7554971
[TBL] [Abstract][Full Text] [Related]
10. Enlarged follicles in women using oral contraceptives.
Broome M; Clayton J; Fotherby K
Contraception; 1995 Jul; 52(1):13-6. PubMed ID: 8521709
[TBL] [Abstract][Full Text] [Related]
11. Iron status in Danish women aged 35-65 years. Relation to menstruation and method of contraception.
Milman N; Rosdahl N; Lyhne N; Jørgensen T; Graudal N
Acta Obstet Gynecol Scand; 1993 Nov; 72(8):601-5. PubMed ID: 8259744
[TBL] [Abstract][Full Text] [Related]
12. [Disease and contraception. Recent aspects].
Rozenbaum H
Contracept Fertil Sex (Paris); 1985 Jan; 13(1 Suppl):431-6. PubMed ID: 12280211
[TBL] [Abstract][Full Text] [Related]
13. Transvaginal sonographic ovarian findings in a random sample of women 25-40 years old.
Borgfeldt C; Andolf E
Ultrasound Obstet Gynecol; 1999 May; 13(5):345-50. PubMed ID: 10380300
[TBL] [Abstract][Full Text] [Related]
14. Pretreatment with an oral contraceptive is effective in reducing the incidence of functional ovarian cyst formation during pituitary suppression by gonadotropin-releasing hormone analogues.
Biljan MM; Mahutte NG; Dean N; Hemmings R; Bissonnette F; Tan SL
J Assist Reprod Genet; 1998 Nov; 15(10):599-604. PubMed ID: 9866068
[TBL] [Abstract][Full Text] [Related]
15. Oral contraceptive use and benign gynecologic conditions. A review.
Chiaffarino F; Parazzini F; La Vecchia C; Ricci E; Crosignani PG
Contraception; 1998 Jan; 57(1):11-8. PubMed ID: 9554245
[TBL] [Abstract][Full Text] [Related]
16. Ovarian reserve assessment in users of oral contraception seeking fertility advice on their reproductive lifespan.
Birch Petersen K; Hvidman HW; Forman JL; Pinborg A; Larsen EC; Macklon KT; Sylvest R; Andersen AN
Hum Reprod; 2015 Oct; 30(10):2364-75. PubMed ID: 26311148
[TBL] [Abstract][Full Text] [Related]
17. [Oral contraception and its beneficial gynecological effects].
Belaisch J; Hommais-loufrani B
Fertil Contracept Sex; 1988 Mar; 16(3 Suppl):3-7. PubMed ID: 12282188
[TBL] [Abstract][Full Text] [Related]
18. Noncontraceptive health benefits of oral steroidal contraceptives.
Mishell DR
Am J Obstet Gynecol; 1982 Mar; 142(6 Pt 2):809-16. PubMed ID: 7065059
[TBL] [Abstract][Full Text] [Related]
19. Oral contraceptive formulation and ovarian cysts: FDA committee finds no increased risk of follicular enlargement with low-dose monophasic or triphasic preparations.
Contracept Rep; 1994 Mar; 5(1):6-9. PubMed ID: 12287739
[TBL] [Abstract][Full Text] [Related]
20. Phasic contraceptive pills and functional ovarian cysts.
Caillouette JC; Koehler AL
Am J Obstet Gynecol; 1987 Jun; 156(6):1538-42. PubMed ID: 3296761
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
